Dual PD-1/PD-L1 and CTLA-4 inhibition strategies: tailoring immunotherapy for metastatic non-small cell lung cancer

被引：0

作者：

Kobayashi, Takayuki ^{[1
]}

Hakozaki, Taiki ^{[1
,2
]}

机构：

[1] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, 3-18-22 Honkomagome,Bunkyo Ku, Tokyo 1130021, Japan

[2] Waseda Univ, Fac Sci & Engn, Grad Sch Adv Sci & Engn, Tokyo, Japan

来源：

CHINESE CLINICAL ONCOLOGY | 2024年 / 13卷 / 04期

关键词：

Immune checkpoint inhibitors (ICIs); non-small cell lung cancer (NSCLC); programmed death ligand-1 (PD-L1); cytotoxic T-lymphocyte antigen 4 (CTLA-4); dual immunotherapy (dual ITx); IMMUNITY; TREMELIMUMAB; DURVALUMAB; PHASE-3;

D O I：

10.21037/cco-24-20

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：6

共 22 条

[1] Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis [J].

Borghaei, H. ;

Ciuleanu, T. -E. ;

Lee, J. -S ;

Pluzanski, A. ;

Caro, R. Bernabe ;

Gutierrez, M. ;

Ohe, Y. ;

Nishio, M. ;

Goldman, J. ;

Ready, N. ;

Spigel, D. R. ;

Ramalingam, S. S. ;

Paz-Ares, L. G. ;

Gainor, J. F. ;

Ahmed, S. ;

Reck, M. ;

Maio, M. ;

O'Byrne, K. J. ;

Memaj, A. ;

Nathan, F. ;

Tran, P. ;

Hellmann, M. D. ;

Brahmer, J. R. .

ANNALS OF ONCOLOGY, 2023, 34 (02) :173-185

[2] Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227 [J].

Brahmer, Julie R. ;

Lee, Jong-Seok ;

Ciuleanu, Tudor-Eliade ;

Bernabe Caro, Reyes ;

Nishio, Makoto ;

Urban, Laszlo ;

Audigier-Valette, Clarisse ;

Lupinacci, Lorena ;

Sangha, Randeep ;

Pluzanski, Adam ;

Burgers, Jacobus ;

Mahave, Mauricio ;

Ahmed, Samreen ;

Schoenfeld, Adam J. ;

Paz-Ares, Luis G. ;

Reck, Martin ;

Borghaei, Hossein ;

O'Byrne, Kenneth J. ;

Gupta, Ravi G. ;

Bushong, Judith ;

Li, Li ;

Blum, Steven I. ;

Eccles, Laura J. ;

Ramalingam, Suresh S. .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (06) :1200-+

[3] Oncology Meets Immunology: The Cancer-Immunity Cycle [J].

Chen, Daniel S. ;

Mellman, Ira .

IMMUNITY, 2013, 39 (01) :1-10

[4] NEPTUNE China cohort: First-line durvalumab plus tremelimumab in Chinese patients with metastatic non-small-cell lung cancer [J].

Cheng, Ying ;

Zhou, Qing ;

Han, Baohui ;

Fan, Yun ;

Shan, Li ;

Chang, Jianhua ;

Sun, Si ;

Fang, Jian ;

Chen, Yuan ;

Sun, Jianguo ;

Wu, Gang ;

Mann, Helen ;

Naicker, Kirsha ;

Shire, Norah ;

Mok, Tony ;

de Castro Jr, Gilberto .

LUNG CANCER, 2023, 178 :87-95

[5] NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC [J].

de Castro Jr, Gilberto ;

Rizvi, Naiyer A. ;

Schmid, Peter ;

Syrigos, Konstantinos ;

Martin, Claudio ;

Yamamoto, Nobuyuki ;

Cheng, Ying ;

Moiseyenko, Vladimir ;

Summers, Yvonne ;

Vynnychenko, Ihor ;

Lee, Sung Yong ;

Bryl, Maciej ;

Zer, Alona ;

Erman, Mustafa ;

Timcheva, Constanta ;

Raja, Rajiv ;

Naicker, Kirsha ;

Scheuring, Urban ;

Walker, Jill ;

Mann, Helen ;

Chand, Vikram ;

Mok, Tony .

JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (01) :106-119

[6] Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score=1% in the KEYNOTE-042 Study [J].

de Castro Jr, Gilberto ;

Kudaba, Iveta ;

Wu, Yi-Long ;

Lopes, Gilberto ;

Kowalski, Dariusz M. ;

Turna, Hande Z. ;

Caglevic, Christian ;

Zhang, Li ;

Karaszewska, Boguslawa ;

Laktionov, Konstantin K. ;

Srimuninnimit, Vichien ;

Bondarenko, Igor ;

Kubota, Kaoru ;

Mukherjee, Rinee ;

Lin, Jianxin ;

Souza, Fabricio ;

Mok, Tony S. K. ;

Cho, Byoung Chul .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (11) :1986-+

[7] Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer [J].

Garon, Edward B. ;

Rizvi, Naiyer A. ;

Hui, Rina ;

Leighl, Natasha ;

Balmanoukian, Ani S. ;

Eder, Joseph Paul ;

Patnaik, Amita ;

Aggarwal, Charu ;

Gubens, Matthew ;

Horn, Leora ;

Carcereny, Enric ;

Ahn, Myung-Ju ;

Felip, Enriqueta ;

Lee, Jong-Seok ;

Hellmann, Matthew D. ;

Hamid, Omid ;

Goldman, Jonathan W. ;

Soria, Jean-Charles ;

Dolled-Filhart, Marisa ;

Rutledge, Ruth Z. ;

Zhang, Jin ;

Lunceford, Jared K. ;

Rangwala, Reshma ;

Lubiniecki, Gregory M. ;

Roach, Charlotte ;

Emancipator, Kenneth ;

Gandhi, Leena .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21) :2018-2028

[8] Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC [J].

Herbst, Roy S. ;

Giaccone, Giuseppe ;

de Marinis, Filippo ;

Reinmuth, Niels ;

Vergnenegre, Alain ;

Barrios, Carlos H. ;

Morise, Masahiro ;

Felip, Enriqueta ;

Andric, Zoran ;

Geater, Sarayut ;

Ozguroglu, Mustafa ;

Zou, Wei ;

Sandler, Alan ;

Enquist, Ida ;

Komatsubara, Kimberly ;

Deng, Yu ;

Kuriki, Hiroshi ;

Wen, Xiaohui ;

McCleland, Mark ;

Mocci, Simonetta ;

Jassem, Jacek ;

Spigel, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (14) :1328-1339

[9] Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study [J].

Johnson, Melissa L. ;

Cho, Byoung Chul ;

Luft, Alexander ;

Alatorre-Alexander, Jorge ;

Geater, Sarayut Lucien ;

Laktionov, Konstantin ;

Kim, Sang-We ;

Ursol, Grygorii ;

Hussein, Maen ;

Lim, Farah Louise ;

Yang, Cheng-Ta ;

Araujo, Luiz Henrique ;

Saito, Haruhiro ;

Reinmuth, Niels ;

Shi, Xiaojin ;

Poole, Lynne ;

Peters, Solange ;

Garon, Edward B. ;

Mok, Tony .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (06) :1213-+

[10] Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma [J].

Larkin, J. ;

Chiarion-Sileni, V. ;

Gonzalez, R. ;

Grob, J-J ;

Rutkowski, P. ;

Lao, C. D. ;

Cowey, C. L. ;

Schadendorf, D. ;

Wagstaff, J. ;

Dummer, R. ;

Ferrucci, P. F. ;

Smylie, M. ;

Hogg, D. ;

Hill, A. ;

Marquez-Rodas, I. ;

Haanen, J. ;

Guidoboni, M. ;

Maio, M. ;

Schoffski, P. ;

Carlino, M. S. ;

Lebbe, C. ;

McArthur, G. ;

Ascierto, P. A. ;

Daniels, G. A. ;

Long, G. V. ;

Bastholt, L. ;

Rizzo, J. I. ;

Balogh, A. ;

Moshyk, A. ;

Hodi, F. S. ;

Wolchok, J. D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (16) :1535-1546

← 1 2 3 →